Bipolar Disorder Therapeutics Drugs Market Report

Global and Region Bipolar Disorder Therapeutics Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：195
  • REPORT CODE：GMM938038
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Bipolar Disorder Therapeutics Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Bipolar Disorder Therapeutics Drugsmarket, defines the market attractiveness level of Bipolar Disorder Therapeutics Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Bipolar Disorder Therapeutics Drugs industry, describes the types of Bipolar Disorder Therapeutics Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Bipolar Disorder Therapeutics Drugs market and the development prospects and opportunities of Bipolar Disorder Therapeutics Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Bipolar Disorder Therapeutics Drugs market in Chapter 13.

    By Player:

    • GSK

    • Bristol-Myers Squibb

    • Otsuka

    • Lundbeck

    • Janssen

    • Delpor

    • Novartis Pharmaceuticals Corporation

    • AbbVie

    • Intra-Cellular Therapies

    • AstraZeneca

    • Youdim

    • Allergan

    • Reviva Pharmaceuticals

    • Noven Pharmaceuticals

    • Pfizer

    By Type:

    • Olanzapine (Zyprexa)

    • Quetiapine (Seroquel)

    • Risperidone (Risperdal)

    • Ariprazole (Abilify)

    • Ziprasidone (Geodon)

    • Clozapine (Clozaril)

    By End-User:

    • lumateperone

    • Central Nervous System (CNS) Disorders

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Bipolar Disorder Therapeutics Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Bipolar Disorder Therapeutics Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Bipolar Disorder Therapeutics Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Bipolar Disorder Therapeutics Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Bipolar Disorder Therapeutics Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Bipolar Disorder Therapeutics Drugs Consumption (2017-2022)

    • 7.2 United States Bipolar Disorder Therapeutics Drugs Consumption (2017-2022)

    • 7.3 Europe Bipolar Disorder Therapeutics Drugs Consumption (2017-2022)

    • 7.4 China Bipolar Disorder Therapeutics Drugs Consumption (2017-2022)

    • 7.5 Japan Bipolar Disorder Therapeutics Drugs Consumption (2017-2022)

    • 7.6 India Bipolar Disorder Therapeutics Drugs Consumption (2017-2022)

    • 7.7 South Korea Bipolar Disorder Therapeutics Drugs Consumption (2017-2022)

    8 Region and Country-wise Bipolar Disorder Therapeutics Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Bipolar Disorder Therapeutics Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Bipolar Disorder Therapeutics Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Bipolar Disorder Therapeutics Drugs Consumption Forecast (2022-2028)

    • 8.4 China Bipolar Disorder Therapeutics Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Bipolar Disorder Therapeutics Drugs Consumption Forecast (2022-2028)

    • 8.6 India Bipolar Disorder Therapeutics Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Bipolar Disorder Therapeutics Drugs Consumption Forecast (2022-2028)

    9 Global Bipolar Disorder Therapeutics Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Olanzapine (Zyprexa) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Quetiapine (Seroquel) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Risperidone (Risperdal) Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Ariprazole (Abilify) Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Ziprasidone (Geodon) Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Clozapine (Clozaril) Consumption and Growth Rate (2017-2022)

    • 9.2 Global Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global lumateperone Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Central Nervous System (CNS) Disorders Consumption and Growth Rate (2017-2022)

    10 Global Bipolar Disorder Therapeutics Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Bipolar Disorder Therapeutics Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Olanzapine (Zyprexa) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Quetiapine (Seroquel) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Risperidone (Risperdal) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Ariprazole (Abilify) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Ziprasidone (Geodon) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Clozapine (Clozaril) Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Bipolar Disorder Therapeutics Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global lumateperone Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Central Nervous System (CNS) Disorders Consumption Forecast and Growth Rate (2022-2028)

    11 Global Bipolar Disorder Therapeutics Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Bipolar Disorder Therapeutics Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Bipolar Disorder Therapeutics Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Bipolar Disorder Therapeutics Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Bipolar Disorder Therapeutics Drugs Market Competitive Analysis

    • 14.1 GSK

      • 14.1.1 GSK Company Details

      • 14.1.2 GSK Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 GSK Bipolar Disorder Therapeutics Drugs Product and Service

    • 14.2 Bristol-Myers Squibb

      • 14.2.1 Bristol-Myers Squibb Company Details

      • 14.2.2 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Product and Service

    • 14.3 Otsuka

      • 14.3.1 Otsuka Company Details

      • 14.3.2 Otsuka Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Otsuka Bipolar Disorder Therapeutics Drugs Product and Service

    • 14.4 Lundbeck

      • 14.4.1 Lundbeck Company Details

      • 14.4.2 Lundbeck Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Lundbeck Bipolar Disorder Therapeutics Drugs Product and Service

    • 14.5 Janssen

      • 14.5.1 Janssen Company Details

      • 14.5.2 Janssen Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Janssen Bipolar Disorder Therapeutics Drugs Product and Service

    • 14.6 Delpor

      • 14.6.1 Delpor Company Details

      • 14.6.2 Delpor Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Delpor Bipolar Disorder Therapeutics Drugs Product and Service

    • 14.7 Novartis Pharmaceuticals Corporation

      • 14.7.1 Novartis Pharmaceuticals Corporation Company Details

      • 14.7.2 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Product and Service

    • 14.8 AbbVie

      • 14.8.1 AbbVie Company Details

      • 14.8.2 AbbVie Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 AbbVie Bipolar Disorder Therapeutics Drugs Product and Service

    • 14.9 Intra-Cellular Therapies

      • 14.9.1 Intra-Cellular Therapies Company Details

      • 14.9.2 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Product and Service

    • 14.10 AstraZeneca

      • 14.10.1 AstraZeneca Company Details

      • 14.10.2 AstraZeneca Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 AstraZeneca Bipolar Disorder Therapeutics Drugs Product and Service

    • 14.11 Youdim

      • 14.11.1 Youdim Company Details

      • 14.11.2 Youdim Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Youdim Bipolar Disorder Therapeutics Drugs Product and Service

    • 14.12 Allergan

      • 14.12.1 Allergan Company Details

      • 14.12.2 Allergan Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Allergan Bipolar Disorder Therapeutics Drugs Product and Service

    • 14.13 Reviva Pharmaceuticals

      • 14.13.1 Reviva Pharmaceuticals Company Details

      • 14.13.2 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product and Service

    • 14.14 Noven Pharmaceuticals

      • 14.14.1 Noven Pharmaceuticals Company Details

      • 14.14.2 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product and Service

    • 14.15 Pfizer

      • 14.15.1 Pfizer Company Details

      • 14.15.2 Pfizer Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Pfizer Bipolar Disorder Therapeutics Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Bipolar Disorder Therapeutics Drugs

    • Figure Bipolar Disorder Therapeutics Drugs Picture

    • Table Global Bipolar Disorder Therapeutics Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Bipolar Disorder Therapeutics Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Bipolar Disorder Therapeutics Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Bipolar Disorder Therapeutics Drugs Consumption by Country (2017-2022)

    • Figure United States Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Bipolar Disorder Therapeutics Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Bipolar Disorder Therapeutics Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Bipolar Disorder Therapeutics Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Bipolar Disorder Therapeutics Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Bipolar Disorder Therapeutics Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Bipolar Disorder Therapeutics Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Bipolar Disorder Therapeutics Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Olanzapine (Zyprexa) Consumption and Growth Rate (2017-2022)

    • Figure Global Quetiapine (Seroquel) Consumption and Growth Rate (2017-2022)

    • Figure Global Risperidone (Risperdal) Consumption and Growth Rate (2017-2022)

    • Figure Global Ariprazole (Abilify) Consumption and Growth Rate (2017-2022)

    • Figure Global Ziprasidone (Geodon) Consumption and Growth Rate (2017-2022)

    • Figure Global Clozapine (Clozaril) Consumption and Growth Rate (2017-2022)

    • Figure Global lumateperone Consumption and Growth Rate (2017-2022)

    • Figure Global Central Nervous System (CNS) Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Olanzapine (Zyprexa) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Quetiapine (Seroquel) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Risperidone (Risperdal) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ariprazole (Abilify) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ziprasidone (Geodon) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clozapine (Clozaril) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global lumateperone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Central Nervous System (CNS) Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Bipolar Disorder Therapeutics Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Bipolar Disorder Therapeutics Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Bipolar Disorder Therapeutics Drugs Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Product and Service

    • Table Otsuka (Foundation Year, Company Profile and etc.)

    • Table Otsuka Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Otsuka Bipolar Disorder Therapeutics Drugs Product and Service

    • Table Lundbeck (Foundation Year, Company Profile and etc.)

    • Table Lundbeck Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lundbeck Bipolar Disorder Therapeutics Drugs Product and Service

    • Table Janssen (Foundation Year, Company Profile and etc.)

    • Table Janssen Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Bipolar Disorder Therapeutics Drugs Product and Service

    • Table Delpor (Foundation Year, Company Profile and etc.)

    • Table Delpor Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Delpor Bipolar Disorder Therapeutics Drugs Product and Service

    • Table Novartis Pharmaceuticals Corporation (Foundation Year, Company Profile and etc.)

    • Table Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Bipolar Disorder Therapeutics Drugs Product and Service

    • Table Intra-Cellular Therapies (Foundation Year, Company Profile and etc.)

    • Table Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Bipolar Disorder Therapeutics Drugs Product and Service

    • Table Youdim (Foundation Year, Company Profile and etc.)

    • Table Youdim Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Youdim Bipolar Disorder Therapeutics Drugs Product and Service

    • Table Allergan (Foundation Year, Company Profile and etc.)

    • Table Allergan Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Bipolar Disorder Therapeutics Drugs Product and Service

    • Table Reviva Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product and Service

    • Table Noven Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Bipolar Disorder Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Bipolar Disorder Therapeutics Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US